20970 ⎘
Medicinal preparations containing peptides; Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans; Cytokines; Lymphokines; Interferons; Interleukins [IL] IL-7
USE OF INTERLEUKIN-7 AND CHIMERIC ANTIGEN RECEPTOR (CAR)-BEARING IMMUNE EFFECTOR CELLS FOR TREATING TUMOR
#2METHODS FOR IMPROVING COGNITIVE FUNCTION
#3Methods of Treating Glioblastoma
#4METHODS OF TRANSDUCTION USING A VIRAL VECTOR AND INHIBITORS OF ANTIVIRAL RESTRICTION FACTORS
#5CHIMERIC ANTIGEN RECEPTOR THERAPIES FOR TREATING CANCER WITH IL7Fc ARMORED CAR-T CELLS
#6IMMUNOGENS AND METHODS FOR INDUCING AN IMMUNE RESPONSE
#7IL7-IL15 TxM Compositions and Methods
#8FORMULATION OF MODIFIED INTERLEUKIN-7 FUSION PROTEIN
#9PHARMACEUTICAL COMPOSITION COMPRISING IMMUNOGLOBULIN FC-FUSED INTERLEUKIN-7 FUSION PROTEIN FOR PREVENTING OR TREATING HUMAN PAPILLOMAVIRUS-CAUSED DISEASES
#10Photolysis to Unlock Caged Protein Therapeutics
#11TRIPLE COMBINATION DRUG DOSING THERAPY FOR HEAD AND NECK CANCER TREATMENT
#12THERAPEUTIC NUCLEIC ACID MOLECULE, MIXTURE, AND DRUG, AND USE THEREOF IN TREATING SOLID TUMOR
#13ALUMINUM NANOCRYSTALLINE COMPOSITE IMMUNE DRUG AND PREPARATION METHOD THEREFOR AND USE THEREOF
#14METHOD OF TREATING A TUMOR WITH A COMBINATION OF IL-7 PROTEIN AND VEGF ANTAGONIST
#15BIOMARKERS AND TREATMENT METHODS FOR TRAUMATIC BRAIN INJURY-ASSOCIATED IMPAIRMENTS
#16IMPLANTABLE SCAFFOLDS FOR IMMUNOTHERAPEUTIC AND OTHER USES
#17OXAZAPHOSPHORINE ANTIBODY DRUG CONJUGATES AND METHODS OF USE
#18METHOD OF TREATING CANCER WITH A CANCER THERAPY IN COMBINATION WITH ANOTHER THERAPEUTIC AGENT
#19COMBINATIONS OF CHECKPOINT INHIBITORS AND THERAPEUTICS TO TREAT CANCER
#20COMBINATIONS OF CHECKPOINT INHIBITORS AND THERAPEUTICS TO TREAT CANCER
#21CANCER TREATMENT AGENT
#22BIOLOGIC FOR THE TREATMENT OF CANCER
#23THERAPEUTIC RNA FOR TREATING CANCER
#24ALTERNATIVE PD1-IL7V IMMUNOCONJUGATES FOR THE TREATMENT OF CANCER
#25MODIFIED GRANULOCYTE COLONY-STIMULATING FACTOR (G-CSF) AND CHIMERIC CYTOKINE RECEPTORS BINDING SAME
#26METHODS AND COMPOSITIONS FOR PRODUCING AN ADENOVIRUS VECTOR FOR USE WITH MULTIPLE VACCINATIONS
#27COMPOSITION FOR PREVENTING OR TREATING CANCER COMPRISING DUAL EXPRESSIONVECTOR FOR SIMULTANEOUSLY EXPRESSING PROTEIN PRESENT IN CELL AND PROTEIN SECRETED OUT OF CELL
#28METHODS OF IDENTIFYING METASTATIC LESIONS IN A PATIENT AND TREATING THEREOF
#29NANT CANCER VACCINE STRATEGIES
#30PHARMACEUTICAL COMPOSITION COMPRISING IMMUNOGLOBULIN FC-FUSED INTERLEUKIN-7 FUSION PROTEIN FOR PREVENTING OR TREATING HUMAN PAPILLOMAVIRUS-CAUSED DISEASES
#31Agents and Methods for Increasing Liver Immune Response
#32METHODS OF INDUCING STEM CELL MOBILIZATION
#33METHODS AND COMPOSITIONS FOR PRODUCING AN ADENOVIRUS VECTOR FOR USE WITH MULTIPLE VACCINATIONS
#34IL-7Rαγc ligand immunoglobulin fusion proteins
#35COMPOSITIONS AND METHODS FOR IN VIVO GENERATION OF CAR EXPRESSING CELLS
#36THERAPEUTIC HYDROGEL FOR THE DELIVERY OF CAR-T CELLS
#37Cancer prevention and therapy by inhibiting soluble tumor necrosis factor
#38TREATMENT OF CANCER WITH IMMUNE STIMULATORS
#39FORMULATION OF MODIFIED INTERLEUKIN-7 FUSION PROTEIN
#40METHOD
#41TREATMENT OF IMMUNE DEPRESSION
#42METHOD OF TREATING A SOLID TUMOR WITH A COMBINATION OF AN IL-7 PROTEIN AND CAR-BEARING IMMUNE CELLS
#43ANTIGEN BINDING PROTEINS, COMPOSITIONS, AND METHODS OF USING THEREOF
#44GLYPICAN-2-BINDING MOIETIES, CHIMERIC ANTIGEN RECEPTORS AND USES THEREOF
#45BIFUNCTIONAL ANTI-PD-1/IL-7 MOLECULE
#46Methods and compositions for producing an adenovirus vector for use with multiple vaccinations
#47MODULATING GAMMA-C-CYTOKINE ACTIVITY
#48METHOD OF TREATING A TUMOR WITH A COMBINATION OF IL-7 PROTEIN AND A BISPECIFIC ANTIBODY
#49Methods of Treating Glioblastoma
#50Nant Cancer Vaccine
#51METHOD FOR PREVENTING OR TREATING INFLUENZA VIRUS INFECTION USING PHARMACEUTICAL COMPOSITION COMPRISING IMMUNOGLOBULIN FC-FUSED INTERLEUKIN-7 FUSION PROTEIN
#52Drug for Treating Cancer, Combination Drug, Drug Composition, Immune Responsive Cell, Nucleic Acid Delivery Vehicle, and Product
#53Methods and compositions for producing an adenovirus vector for use with multiple vaccinations
#54TREATMENT OF CANCERS WITH GM-CSF ANTAGONISTS
#55Photolysis to unlock caged protein therapeutics
#56METHOD FOR INCREASING LYMPHOCYTE COUNT BY USING IL-7 FUSION PROTEIN IN TUMORS
#57GENETICALLY ENGINEERED ONCOLYTIC VACCINIA VIRUSES AND METHODS OF USES THEREOF
#58Methods and compositions for producing an adenovirus vector for use with multiple vaccinations
#59THERAPEUTIC COMPOSITIONS AND METHODS FOR TREATING CANCER IN COMBINATION WITH ANALOGS OF INTERLEUKIN PROTEINS
#60COMBINATION OF PD-1 INHIBITORS AND LAG-3 INHIBITORS FOR ENHANCED EFFICACY IN TREATING CANCER
#61CELL CULTURE FOR TREATING DISEASE IN THE LOWER LIMBS
#62FORMULATION AND TREATMENT FOR OPHTHALMIC DISORDERS
#63Compositions And Methods For Viral Delivery Of Neoepitopes And Uses Thereof
#64DERIVATIVES OF GYLCERO-MANNO-HEPTOSE ADP FOR USE IN MODULATING IMMUNE RESPONSE
#65T CELL RECEPTORS AND METHODS OF USE THEREOF
#66METHODS FOR IMPROVING COGNITIVE FUNCTION
#67METHOD OF TREATING A TUMOR WITH A COMBINATION OF IL-7 PROTEIN AND AN IMMUNE CHECKPOINT INHIBITOR
#68METHODS OF TREATING TIM-3 ELEVATION
#69Nant cancer vaccine
#70Cancer therapy by combination use of oncolytic vaccinia virus and immune checkpoint inhibitor, and pharmaceutical composition and combination medicine for use in the cancer therapy
#71USE OF INTERLEUKIN-7 AND CHIMERIC ANTIGEN RECEPTOR (CAR)-BEARING IMMUNE EFFECTOR CELLS FOR TREATING TUMOR
#72IL7-IL15 TxM Compositions and Methods
#73Biomarkers and treatment methods for traumatic brain injury-associated impairments
#74BIO-MIMETIC FORMULATION
#75COMPOSITIONS AND METHODS FOR TREATING CANCER WITH ATYPICAL BRAF MUTATIONS
#76Biologic for the treatment of cancer
#77SKIN OINTMENT FOR TREATING LABIA MINORA SKIN
#78METHODS AND COMPOSITIONS FOR MODULATING THYMIC FUNCTION
#79ALDOXORUBICIN COMBINATION TREATMENTS AND METHODS
#80NOVEL GENETICALLY ENGINEERED VACCINIA VIRUSES
#81Compositions and methods for viral delivery of neoepitopes and uses thereof
#82Treatment of cancer with alpha thymosin peptide and PD-1 inhibitors
#83Methods and compositions for producing an adenovirus vector for use with multiple vaccinations
#84Method of treating cancer with a cancer therapy in combination with another therapeutic agent
#85Nant cancer vaccine
#86Cancer prevention and therapy by inhibiting soluble tumor necrosis factor
#87Coordinated multi-prong cancer therapy
#88Compositions for biological systems and methods for preparing and using the same
#89STEROID ADMINISTRATION AND IMMUNOTHERAPY
#90Cancer prevention and therapy by inhibiting soluble tumor necrosis factor
#91Nant cancer vaccine strategies
#92Packaging cell for making a pseudotyped lentivirus
#93METHODS OF USING INTERLEUKIN-10 FOR TREATING DISEASES AND DISORDERS
#94Engineered CD46-specific effector cells and uses thereof in the treatment of cancer
#95CONJUGATES OF AN IL-7 MOIETY AND A POLYMER
#96BIO-MIMETIC FORMULATION
#97Interleukin Combination and Use Thereof
#98Method of Modulating Fibroblast Accumulation or Collagen Deposition
#99TRANSFECTION OF DENDRITIC CELLS AND METHODS THEREFOR
#100Compositions and methods related to polycytotoxic T cells
#101Modulating gamma-c-cytokine activity
#102THERAPEUTIC COMPOSITIONS FOR THE TREATMENT OF DRY EYE AND RELATED OCULAR SURFACE DISEASES
#103Compositions and methods for viral delivery of neoepitopes and uses thereof
#104LIPID VESICLE COMPOSITIONS AND METHODS OF USE
#105Method for preventing or treating influenza virus infection using pharmaceutical composition comprising immunoglobulin Fc-fused interleukin-7 fusion protein
#106Formulation of modified interleukin-7 fusion protein
#107Pharmaceutical composition comprising immunoglobulin Fc-fused interleukin-7 fusion protein for preventing or treating human papillomavirus-caused diseases
#108Conjugates of GM-CSF and IL-7, and Compositions Thereof
#109Compositions for biological systems and methods for preparing and using the same
#110LIPID VESICLE COMPOSITIONS AND METHODS OF USE
#111Methods of delivering a pseudotyped lentivirus
#112TREATMENT OF CANCER WITH IMMUNE STIMULATORS
#113Methods and compositions for enhancing the therapeutic effect of anti-tumor T cells
#114Methods and compositions in diagnosis of chronic fatigue syndrome/myalgic encephalomyelitis
#115Genetically engineered vaccinia viruses
#116Method for treatment of metastatic and refractory cancers and tumors with an inducer that overcomes inhibition of T cell proliferation
#117IL-15 and IL-15Rα heterodimer dose escalation regimens for treating conditions
#118Cytotoxic T lymphocyte inducing immunogens for prevention treatment and diagnosis of cancer
#119CANCER-TARGETED IL-12 IMMUNOTHERAPY
#120HPV vaccines and methods of use thereof
#121Breast cancer vaccines and methods of use thereof
#122Lipid vesicle compositions and methods of use
#123Method for treatment of metastatic and refractory cancers and tumors with an inducer that overcomes inhibition of T cell proliferation
#124WOUND HEALING COMPOSITION
#125METHOD AND COMPOSITION FOR THE TREATMENT OF MODERATE TO SEVERE KERATOCONJUNCTIVITIS SICCA
#126Recombinant retrovirus pseudotyped with E2 alphavirus glycoprotein
#127Method of immunotherapy for treatment of human papillomavirus infection
#128Uses of conjugates of GM-CSF and IL-7 to treat viral infections
#129Modulation of γδ T cells
#130Enhancing progenitor cell numbers
#131Treatment of cancer with immune stimulators
#132Methods and compositions for enhancing the therapeutic effect of anti-tumor T cells
#133Lipid vesicle compositions and methods of use
#134PHARMACEUTICAL COMPOSITION FOR CANCER TREATMENT INCLUDING FUSION PROTEIN
#135Preeclamptic placental mesenchymal stem cell conditioned medium for use in the treatment of a tumour
#136CELLS, COMPOSITIONS, AND TREATMENT METHODS FOR STIMULATION OF HEMATOPOIESIS
#137TARGETED VECTORS FOR CANCER IMMUNOTHERAPY
#138Skin cream
#139HCV IMMUNOTHERAPY
#140Polyoma virus JC peptides and proteins in vaccination and diagnostic applications
#141Methods and compositions for enhancing the therapeutic effect of anti-tumor T cells
#142Cytotoxic T lymphocyte inducing immunogens for prevention treatment and diagnosis of cancer
#143Compositions comprising a Brd4 antagonist and methods for the treatment of HIV
#144T-cell vaccination with viral vectors via mechanical epidermal disruption
#145CANCER THERAPY BY EX VIVO ACTIVATED AUTOLOGOUS IMMUNE CELLS
#146Adoptive cell therapy with young T cells
#147Methods for Treating Patients Undergoing Multi-Cycle Chemotherapy
#148Sequential administration of a replication defective adenovirus vector in vaccination protocols
#149USE OF AUTOLOGOUS EFFECTOR CELLS AND ANTIBODIES FOR TREATMENT OF MULTIPLE MYELOMA
#150USE OF AUTOLOGOUS EFFECTOR CELLS FOR TREATMENT OF MULTIPLE MYELOMA
#151Method of immunotherapy for treament of human papillomavirus infection
#152Skin cream
#153Lipid vesicle compositions and methods of use
#154Targeted gene delivery to dendritic cells
#155Bacterial ghosts for mediating innate immunity
#156Method And Composition For The Treatment Of Moderate To Severe Keratoconjunctivitis Sicca
#157T-cell vaccination with viral vectors via mechanical epidermal disruption
#158Immunotherapy with in vitro-selected antigen-specific lymphocytes after nonmyeloablative lymphodepleting chemotherapy
#159IL-7 fusion proteins
#160METHOD OF MODULATING FIBROBLAST ACCUMULATION OR COLLAGEN DEPOSITION
#161Adoptive cell therapy with young T cells
#162METHODS AND COMPOSITIONS FOR EXPANDING T REGULATORY CELLS
#163Targeted vectors for cancer immunotherapy
#164Sequential administration of a replication defective adenovirus vector in vaccination protocols
#165METHOD FOR TREATING CANCER IN HUMANS
#166Recombiant lentivirus comprising an E2 alphavirus glycoprotein that binds to DC-SIGN
#167Packaging cells for producing retrovirus pseudotyped with an E2 alphavirus glycoprotein
#168Uses of mammalian cytokines and agonists; related reagents
#169Composition for delivery of hematopoietic growth factor
#170Enterotoxin gene cluster (egc) superantigens to treat malignant disease
#171IL-7 fusion proteins
#172Targeted gene delivery for dendritic cell vaccination
#173Tolerance to Graft Prior to Thymic Reactivation
#174Immunoglobulins with Potent and Broad Antiviral Activity
#175Methods and compositions for expanding T regulatory cells
#176Targeted vectors for cancer immunotherapy
#177Treatment for multiple sclerosis
#178Compositions and methods of treating fibrotic disorders
#179Immunotherapy with in vitro-selected antigen-specific lymphocytes after non-myeloablative lymphodepleting chemotherapy
#180IL-7 fusion proteins
#181Composition for delivery of hematopoietic growth factor
#182Composition for delivery of hematopoietic growth factor
#183Composition for delivery of hematopoietic growth factor
#184Method for treating cancer in humans
#185Uses of mammalian cytokines and agonists; related reagents